A study of cyclic nucleotides as second messengers after interleukin 2 stimulation of human T lymphocytes

T E Knudsen, C S Larsen, H E Johnsen

Research output: Contribution to journalJournal articleResearchpeer-review

8 Citations (Scopus)

Abstract

Interleukin 2 (IL-2) was shown to induce a small but significant increase in the level of cGMP after 20 min stimulation and a subsequent fall after 1 h in activated T lymphocytes. No change in the level of cAMP was observed. Addition of the cyclic nucleotide analogues dbcAMP or dbcGMP did not stimulate DNA synthesis. On the contrary, IL-2-induced [3H]thymidine incorporation was inhibited by these drugs. Further, the phosphodiesterase inhibitor theophylline inhibited proliferation of activated T lymphocytes. Our results indicate that neither cAMP nor cGMP act as 'second messengers' for IL-2 but support the theory that cAMP is a negative regulator of cell proliferation.

Original languageEnglish
JournalScandinavian Journal of Immunology. Supplement
Volume25
Issue number5
Pages (from-to)527-31
Number of pages5
ISSN0300-9475
Publication statusPublished - May 1987
Externally publishedYes

Keywords

  • Bucladesine
  • Dibutyryl Cyclic GMP
  • Humans
  • Interleukin-2
  • Lymphocyte Activation
  • Nucleotides, Cyclic
  • Receptors, Immunologic
  • Receptors, Interleukin-2
  • T-Lymphocytes
  • Theophylline

Fingerprint

Dive into the research topics of 'A study of cyclic nucleotides as second messengers after interleukin 2 stimulation of human T lymphocytes'. Together they form a unique fingerprint.

Cite this